European User Group Meeting

OncoDEEP® Kit

European User Group Meeting

OncoDEEP® Kit

A unique gathering of OncoDEEP® Kit users from across Europe. This event will facilitate the sharing of experiences, challenges, and best practice when implementing a Comprehensive Genomic Profiling (CGP) solution in routine clinical laboratory practice. Delegates will leave with a clear plan for their own laboratories and organisations.


𝗪𝗵𝗼 𝗶𝘀 𝘁𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗶𝗻𝘁𝗲𝗻𝗱𝗲𝗱 𝗳𝗼𝗿?

 

Limited Places

OncoDNA recognises that it is challenging for many people to gain funding for meetings and therefore is only charging an ‘administration fee’ to ensure that people make a decision to attend the meeting and not waste places by not showing up. The money collected will be donated to a cancer charity as decided by the delegates during the user group meeting.
21st – 22nd October 2024
The Royal Society of Medicine (London)

Discover more

𝗪𝗵𝗼 𝗶𝘀 𝘁𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗶𝗻𝘁𝗲𝗻𝗱𝗲𝗱 𝗳𝗼𝗿?

This event is tailored for Genomic Laboratory Staff, including Professors, Researchers, Heads of Service, Clinical Scientists, Bioinformaticians, Lab Technicians, and more.

It also welcomes Genomic Purchasing Staff, such as buyers, commercial leads, procurement specialists, and distributors, to discuss the latest trends and solutions in genomic technologies.

Lastly, the event is ideal for Oncologists and Nursing Staff with an interest in genomics, providing a platform to explore the cutting-edge applications of genomics in oncology care.

PROGRAMME

Speakers

Prof. Andrew Beggs

Dr. Brigitte Maes

Dr. Brigitte Maes is a distinguished oncologist and researcher with a strong background in medical oncology. She is renowned for her contributions to precision medicine, particularly in the field of comprehensive genomic profiling (CGP). Dr. Maes has played a pivotal role in advancing personalized cancer treatments through her research, which focuses on the practical implementation and clinical benefits of CGP in routine oncology practice. Her work with the Belgium Society of Medical Oncologists (BSMO) and collaborations with various laboratories highlight her dedication to improving patient outcomes by leveraging cutting-edge genomic technologies.

Dr. Gareth Gerrard

Dr. Marcel Trautmann

Dr. Marcel Trautmann is a highly regarded expert in the field of molecular diagnostics and precision oncology. With a robust background in medical research and clinical applications, he has made significant contributions to the integration of advanced genomic technologies into clinical practice. Dr. Trautmann is particularly noted for his work on optimizing next-generation sequencing (NGS) workflows and developing business cases for the adoption of comprehensive genomic profiling (CGP) in laboratories. Dr. Trautmann’s expertise, coupled with his dedication to advancing precision medicine.

Dr. Katya Mokretar

Dr. Katya Mokretar is a Clinical Scientist specializing in molecular oncology, with expertise in leukemia diagnostics and measurable residual disease (MRD) monitoring. Currently serving as Deputy Operations Lead in the Molecular Oncology Unit at Guy’s Hospital, she has extensive experience in next-generation sequencing (NGS) assays for diagnosing hematological malignancies. Her career spans roles in leading cancer genetics departments, where she has advanced genomic diagnostic tools for both leukemia and solid tumors. Dr. Mokretar is a member of prominent scientific organizations, including the European Haematology Association and British Society of Genetic Medicine​ (Synnovis)

MS Lucas Pavlou

Lucas Pavlou is a dedicated professional in the field of molecular diagnostics, with a focus on advancing genomic technologies for clinical applications. With a background in molecular biology and experience in comprehensive genomic profiling (CGP), Lucas has contributed to the implementation of cutting-edge diagnostic tools in lab practices. He is passionate about enhancing patient outcomes through precision medicine and the integration of next-generation sequencing technologies in routine healthcare settings.

Dr. Nicola Foot

Nicola Foot is a dedicated professional in the field of genomics, with expertise in developing innovative strategies for genomic technologies. With experience at the intersection of science and business, Nicola has a proven track record in driving projects from concept to implementation, fostering collaboration across teams, and advancing cutting-edge solutions in the genomics space. Passionate about translating scientific knowledge into real-world applications, Nicola is committed to pushing the boundaries of personalized healthcare and research.

Dr. Philip Beer

Philip joined Step Pharma in June 2021 and was promoted from Vice President, Head of Research & Translation Medicine to Chief Scientific Officer in January 2021. Prior to this, he held senior leadership roles in biotech and biopharma companies, overseeing oncology drug development and biomarker discovery programmes. He is a cofounder of Gabriel Precision Oncology, a clinical software company also focused on improving outcomes for those living with cancer. Philip is a board-certified haematologist with over 16 years of frontline healthcare experience as well as biopharmaceutical industry experience, particularly in translational medicine, drug development, and biomarker discovery.

Philip is a Member of the Royal College of Physicians, UK, and a Fellow of the Royal College of Pathologists, UK. He holds a PhD in molecular cancer biology from the University of Cambridge, UK. Following this he conducted post-doctoral research studies at the BC Cancer Agency, Vancouver, Canada, and has more than 100 peer-reviewed publications. Philip is an Honorary Professor of Translational Medical at the Hull York Medical School, UK.

Dr. Cheng Boon

Dr. Cheng Boon is a highly skilled Consultant Oncologist with extensive experience in the field of oncology. Currently, Dr. Boon serves as a Consultant Oncologist at the University Hospitals of Derby and Burton NHS Foundation Trust, where he has been a key part of the team since June 2023. His role here involves providing expert care to cancer patients, collaborating with multidisciplinary teams, and advancing treatment protocols.

In addition to his position at Derby and Burton, Dr. Boon also holds a full-time consultant role at The Royal Wolverhampton NHS Trust. His work at this esteemed institution further demonstrates his commitment to delivering exceptional care and contributing to the advancement of oncological practices.

Jean-Pol Detiffe

With a strong scientific background, he has founded several companies focused on life sciences and health technologies. His career is marked by a deep commitment to innovation, particularly in developing cutting-edge diagnostic tools and solutions that enhance healthcare outcomes. Detiffe is known for his leadership and ability to bridge the gap between scientific research and practical applications in the industry.

Sebastien Sauvage

Sébastien Sauvage is a dedicated professional at OncoDNA, specializing in the integration of genomic data and personalized cancer care solutions. With a background in engineering and biotechnology, Sébastien plays a pivotal role in developing cutting-edge diagnostic tools that empower oncologists to make informed treatment decisions. His expertise in project management, data analysis, and innovative healthcare solutions helps drive advancements in precision oncology, ultimately improving patient outcomes.

Venue

The Royal Society Of Medicine

1 Wimpole St, London W1G 0AE, United Kingdomine

Registration

Seats are limited for the OncoDEEP Kit European user meeting.
Secure your spot by clicking the button below.

Sponsors

  • Tuesday 24 Sep 2024
  • Monday 21 Oct 2024

Tuesday 24 Sep 2024

1:43 pm

This is session two

Monday 21 Oct 2024

12:25 am

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc venenatis blandit dui sed ornare. Praesent sit amet tortor et nibh euismod dignissim. Aliquam tempus vestibulum massa, eget viverra tellus. Pellentesque metus urna, fringilla quis porttitor at, sodales in quam. Donec sodales ligula nunc, vitae mattis leo facilisis vel.